Liver Fibrosis – Mouse Models and Relevance in Human Liver Diseases

No abstract is available for this paper.

• Publication year

  2013

• Venue

  Zeitschrift für Gastroenterologie - German Journal of Gastroenterology

• Publication date

  2013-01-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1055/s-0032-1330422PMID 23315652
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Fatty liver Shionogi‐ob/ob mouse: A new candidate for a non‐alcoholic steatohepatitis model

  2013cited by this paper
• Hepatocellular carcinoma

  2012cited by this paper
• Dendritic cell regulation of carbon tetrachloride–induced murine liver fibrosis regression

  2012cited by this paper
• Myofibroblasts revert to an inactive phenotype during regression of liver fibrosis

  2012cited by this paper
• Deactivation of hepatic stellate cells during liver fibrosis resolution in mice.

  2012cited by this paper
• Sterile inflammation in the liver.

  2012cited by this paper
• Anti-fibrotic therapy: lost in translation?

  2012cited by this paper
• Elastin accumulation is regulated at the level of degradation by macrophage metalloelastase (MMP‐12) during experimental liver fibrosis

  2012cited by this paper
• Animal models of nonalcoholic fatty liver disease/nonalcoholic steatohepatitis.

  2012cited by this paper
• Hepatitis C virus (HCV) protein expression enhances hepatic fibrosis in HCV transgenic mice exposed to a fibrogenic agent.

  2012cited by this paper
• Tissue transglutaminase does not affect fibrotic matrix stability or regression of liver fibrosis in mice.

  2011cited by this paper
• Absence of hepatic stellate cell retinoid lipid droplets does not enhance hepatic fibrosis but decreases hepatic carcinogenesis

  2011cited by this paper
• Fast food diet mouse: novel small animal model of NASH with ballooning, progressive fibrosis, and high physiological fidelity to the human condition.

  2011cited by this paper
• Pathogenesis of liver fibrosis.

  2011cited by this paper
• Accelerated liver fibrosis in hepatitis B virus transgenic mice: Involvement of natural killer T cells

  2011cited by this paper
• A humanized mouse model to study hepatitis C virus infection, immune response, and liver disease.

  2011cited by this paper
• Hepatic stellate cells require a stiff environment for myofibroblastic differentiation.

  2011cited by this paper
• Lineage tracing demonstrates no evidence of cholangiocyte epithelial‐to‐mesenchymal transition in murine models of hepatic fibrosis

  2011cited by this paper
• A mouse model of cholestasis-associated cholangiocarcinoma and transcription factors involved in progression.

  2011cited by this paper
• Toll-like receptor 4 mediates alcohol-induced steatohepatitis through bone marrow-derived and endogenous liver cells in mice.

  2011cited by this paper
• Hepatocyte-Derived Snail1 Propagates Liver Fibrosis Progression

  2011cited by this paper
• Long‐term entecavir therapy results in the reversal of fibrosis/cirrhosis and continued histological improvement in patients with chronic hepatitis B

  2010cited by this paper
• Macrophages: Master Regulators of Inflammation and Fibrosis

  2010cited by this paper
• Modulation of hepatic fibrosis by c-Jun-N-terminal kinase inhibition.

  2010cited by this paper
• Hepatocytes do not undergo epithelial‐mesenchymal transition in liver fibrosis in mice

  2010cited by this paper
• Snail1 suppresses TGF-β-induced apoptosis and is sufficient to trigger EMT in hepatocytes

  2010cited by this paper
• ALT als Screeningparameter für Lebererkrankungen: eine kritische Evaluation der Evidenz

  2010cited by this paper
• Surgical Treatment of Non-Alcoholic Steatohepatitis and Non-Alcoholic Fatty Liver Disease

  2010cited by this paper
• Apoptosis as a mechanism for liver disease progression.

  2010cited by this paper
• Antagonism of the chemokine Ccl5 ameliorates experimental liver fibrosis in mice.

  2010cited by this paper
• The spectrum of liver diseases related to ABCB4 gene mutations: pathophysiology and clinical aspects.

  2010cited by this paper
• Portal fibroblasts: Underappreciated mediators of biliary fibrosis

  2010cited by this paper
• Macrophage-mediated phagocytosis of apoptotic cholangiocytes contributes to reversal of experimental biliary fibrosis.

  2010cited by this paper
• TAK1 suppresses a NEMO-dependent but NF-kappaB-independent pathway to liver cancer.

  2010cited by this paper
• High‐fructose, medium chain trans fat diet induces liver fibrosis and elevates plasma coenzyme Q9 in a novel murine model of obesity and nonalcoholic steatohepatitis

  2010cited by this paper
• Disruption of TAK1 in hepatocytes causes hepatic injury, inflammation, fibrosis, and carcinogenesis

  2009cited by this paper
• Negligible contribution of bone marrow-derived cells to collagen production during hepatic fibrogenesis in mice.

  2009cited by this paper
• Direct cytopathic effects of particular hepatitis B virus genotypes in severe combined immunodeficiency transgenic with urokinase-type plasminogen activator mouse with human hepatocytes.

  2009cited by this paper
• In vivo gene regulation using tetracycline-regulatable systems

  2009cited by this paper
• Effects of losartan on hepatic expression of nonphagocytic NADPH oxidase and fibrogenic genes in patients with chronic hepatitis C.

  2009cited by this paper
• In liver fibrosis, dendritic cells govern hepatic inflammation in mice via TNF-alpha.

  2009cited by this paper
• CCR1 and CCR5 promote hepatic fibrosis in mice.

  2009cited by this paper
• Spontaneous hepatic fibrosis in transgenic mice overexpressing PDGF-A.

  2008cited by this paper
• Hedgehog signaling regulates epithelial-mesenchymal transition during biliary fibrosis in rodents and humans.

  2008cited by this paper
• Activation of hepatic stellate cells is associated with cytokine expression in thioacetamide-induced hepatic fibrosis in mice

  2008cited by this paper
• Characterization of time‐related changes after experimental bile duct ligation

  2008cited by this paper
• Intragastric ethanol infusion model in rodents.

  2008cited by this paper
• Experimental obstructive cholestasis: the wound-like inflammatory liver response

  2008cited by this paper
• Non-alcoholic fatty liver disease: the mist gradually clears.

  2008cited by this paper
• Liver cirrhosis.

  2008cited by this paper
• Deletion of NEMO/IKKgamma in liver parenchymal cells causes steatohepatitis and hepatocellular carcinoma.

  2007cited by this paper
• Models of liver fibrosis: exploring the dynamic nature of inflammation and repair in a solid organ.

  2007cited by this paper
• Mouse Models of Liver Fibrosis

  2007cited by this paper
• Gene expression profiles during hepatic stellate cell activation in culture and in vivo.

  2007cited by this paper
• TLR4 enhances TGF-beta signaling and hepatic fibrosis.

  2007cited by this paper
• Fibroblasts Derive from Hepatocytes in Liver Fibrosis via Epithelial to Mesenchymal Transition*

  2007cited by this paper
• Animal models of portal hypertension.

  2006cited by this paper
• Bone marrow-derived fibrocytes participate in pathogenesis of liver fibrosis.

  2006cited by this paper
• Liver fibrosis induced by hepatic overexpression of PDGF-B in transgenic mice.

  2006cited by this paper
• Natural killer cells ameliorate liver fibrosis by killing activated stellate cells in NKG2D-dependent and tumor necrosis factor-related apoptosis-inducing ligand-dependent manners.

  2006cited by this paper
• Modeling liver fibrosis in rodents.

  2005cited by this paper
• Tumour necrosis factor α signalling through activation of Kupffer cells plays an essential role in liver fibrosis of non-alcoholic steatohepatitis in mice

  2005cited by this paper
• Platelet-derived growth factor C induces liver fibrosis, steatosis, and hepatocellular carcinoma.

  2005cited by this paper
• Mdr2 (Abcb4)-/- mice spontaneously develop severe biliary fibrosis via massive dysregulation of pro- and antifibrogenic genes.

  2005cited by this paper
• Selective depletion of macrophages reveals distinct, opposing roles during liver injury and repair.

  2005cited by this paper
• Liver fibrosis.

  2005cited by this paper
• Liver-specific deletion of negative regulator Pten results in fatty liver and insulin hypersensitivity

  2004cited by this paper
• Hepatocyte-specific Pten deficiency results in steatohepatitis and hepatocellular carcinomas.

  2004cited by this paper
• NF-kappaB functions as a tumour promoter in inflammation-associated cancer.

  2004cited by this paper
• Spontaneous recovery from micronodular cirrhosis: evidence for incomplete resolution associated with matrix cross-linking.

  2004cited by this paper
• Regurgitation of bile acids from leaky bile ducts causes sclerosing cholangitis in Mdr2 (Abcb4) knockout mice.

  2004cited by this paper
• Lhx2-/- mice develop liver fibrosis.

  2004cited by this paper
• A significant proportion of myofibroblasts are of bone marrow origin in human liver fibrosis.

  2004cited by this paper
• Hepatotoxicity and Mechanism of Action of Haloalkanes: Carbon Tetrachloride as a Toxicological Model

  2003cited by this paper
• Ursodeoxycholic acid aggravates bile infarcts in bile duct-ligated and Mdr2 knockout mice via disruption of cholangioles.

  2002cited by this paper
• Genome-wide analysis of hepatic fibrosis in inbred mice identifies the susceptibility locus Hfib1 on chromosome 15.

  2002cited by this paper
• Leptin is essential for the hepatic fibrogenic response to chronic liver injury.

  2002cited by this paper
• Steatosis and liver cancer in transgenic mice expressing the structural and nonstructural proteins of hepatitis C virus.

  2002cited by this paper
• Repopulation of mouse liver with human hepatocytes and in vivo infection with hepatitis B virus

  2001cited by this paper
• Attenuation of CCl(4)-induced hepatic fibrosis by GdCl(3) treatment or dietary glycine.

  2001cited by this paper
• Hepatitis C virus replication in mice with chimeric human livers

  2001cited by this paper
• Regression of liver fibrosis after biliary drainage in patients with chronic pancreatitis and stenosis of the common bile duct.

  2001cited by this paper
• Histologic Improvement of Fibrosis in Patients with Hepatitis C Who Have Sustained Response to Interferon Therapy

  2000cited by this paper
• CYP2E1 and CYP4A as microsomal catalysts of lipid peroxides in murine nonalcoholic steatohepatitis.

  2000cited by this paper
• Mechanisms of spontaneous resolution of rat liver fibrosis. Hepatic stellate cell apoptosis and reduced hepatic expression of metalloproteinase inhibitors.

  1998cited by this paper
• Pathogenesis of liver fibrosis.

  1997cited by this paper
• PTEN, a Putative Protein Tyrosine Phosphatase Gene Mutated in Human Brain, Breast, and Prostate Cancer

  1997cited by this paper
• Strain-specific differences in mouse hepatic wound healing are mediated by divergent T helper cytokine responses.

  1997cited by this paper
• Transforming growth factors beta 1 and alpha in chronic liver disease. Effects of interferon alfa therapy.

  1991cited by this paper
• Effects of platelet-derived growth factor and other polypeptide mitogens on DNA synthesis and growth of cultured rat liver fat-storing cells.

  1989cited by this paper
• In vitro and in vivo association of transforming growth factor-beta 1 with hepatic fibrosis

  1989cited by this paper
• [Liver cirrhosis].

  1989cited by this paper
• Ethanol‐induced liver fibrosis in rats fed high fat diet

  1986cited by this paper
• Hepatocellular carcinoma.

  1986cited by this paper
• Hepatic lipocytes: the principal collagen-producing cells of normal rat liver.

  1985cited by this paper
• Prolonged bile duct obstruction: a new experimental model for cirrhosis in the rat.

  1984cited by this paper
• Is cirrhosis of the liver experimentally produced by CCl4 and adequate model of human cirrhosis?

  1983cited by this paper
• Liver histopathology in chronic common bile duct stenosis due to chronic alcoholic pancreatitis

  1981cited by this paper
• Fatty liver in the rat after prolonged intake of ethanol with a nutritionally adequate new liquid diet.

  1967cited by this paper
• The reversal of hemochromatotic cirrhosis by multiple phlebotomies. Report of a case.

  1965cited by this paper

• Research progress on the pharmacological properties of active ingredients from Salvia miltiorrhiza: A review.

  2025cites this paper
• Dicrocoeliidae Family: Major Species Causing Veterinary Diseases.

  2024cites this paper
• Stem cell pathology: histogenesis of malignant fibrous histiocytoma and characterization of myofibroblasts appearing in fibrotic lesions

  2023cites this paper
• The Role of Stem Cell Factor, Epidermal Growth Factor and Angiopoietin-2 in HBV, HCV, HCC and NAFLD

  2022cites this paper
• Anticancer effects of Poncirus fructus on hepatocellular carcinoma through regulation of apoptosis, migration, and invasion

  2020cites this paper
• Stiffness and Hepatocytes Function In Vitro

  2020cites this paper
• Depletion of Bone Marrow-Derived Fibrocytes Attenuates TAA-Induced Liver Fibrosis in Mice

  2019cites this paper
• Identification of global mRNA expression profiles and comprehensive bioinformatic analyses of abnormally expressed genes in cholestatic liver disease.

  2019cites this paper
• Dicrocoeliidae Family: Major Species Causing Veterinary Diseases.

  2019cites this paper
• Selective deletion of hepatocyte platelet-derived growth factor receptor α and development of liver fibrosis in mice

  2018cites this paper
• Comparative treatment efficiency of adipose and bone marrow derived allogenic mesenchymal stem cell transplantation in mouse models of liver fibrosis

  2017cites this paper
• Can Ultrasound Imaging Predict the Success of an Experimental Steatofibrosis Model?

  2017cites this paper
• No significant impact of Foxf1 siRNA treatment in acute and chronic CCl4 liver injury

  2017cites this paper
• Substrate stiffness regulates primary hepatocyte functions.

  2015cites this paper
• Tonsil-derived Mesenchymal Stem Cells Ameliorate CCl4–induced Liver Fibrosis in Mice via Autophagy Activation

  2015cites this paper
• Dicrocoeliidae family: major species causing veterinary diseases.

  2014cites this paper
• Pharmacological Inhibition of the Chemokine CXCL16 Diminishes Liver Macrophage Infiltration and Steatohepatitis in Chronic Hepatic Injury

  2014cites this paper
• Establishment of a standardized mouse model of hepatic fibrosis for biomedical research

  2014cites this paper
• Experimental liver fibrosis research: update on animal models, legal issues and translational aspects

  2013cites this paper
• Pharmacological inhibition of the chemokine CCL2 (MCP-1) diminishes liver macrophage infiltration and steatohepatitis in chronic hepatic injury

  2011cites this paper